PHARMACOKINETIC EVALUATION AND TOLERABILITY OF INHALED DRY POWDER LEVODOPA IN PARKINSON'S DISEASE PATIENTS
- Authors
- Publication date
- 1 April 2018
- Publisher
Abstract
Abstract is not available.Similar works
Available Versions
Last time updated on 02/06/2022
Last time updated on 22/04/2023
Last time updated on 22/04/2023
Last time updated on 22/04/2023
Last time updated on 31/03/2019
Last time updated on 03/06/2022
Last time updated on 01/06/2022